Press release
Intravenous Immunoglobulin Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight |Mitsubishi Tanabe Pharma Corporation, Prothya Biosolutions, CSL Behring, AbbVie, Octapharma, Grifols Therapeutics LLC
Intravenous Immunoglobulin Market
Discover which therapies are expected to grab the Intravenous Immunoglobulin Market Share @ Intravenous Immunoglobulin Market Outlook- https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Intravenous Immunoglobulin Market Report
• In April 2025, AbbVie announced a study in broken into 2 parts (dose escalation and safety expansion) with 5 arms. During dose escalation (arms 1-3) participants will receive 1 of 3 doses of ABBV-383 to determine the part 2 doses. After completion of the dose escalation portion of the study, the safety expansion (part 2) portion of the study will begin. Two arms (arm 4-5) will begin and participants will receive 1 of 2 doses as determined during the dose escalation portion (part 1). Around 76 adult participants with relapsed/refractory AL amyloidosis will be enrolled at approximately 20 sites across the world.
• In April 2025, Janssen Research & Development LLC conducted a study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).
• The increase in Intravenous Immunoglobulin Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Intravenous Immunoglobulin Market is anticipated to witness growth at a considerable CAGR.
• The leading Intravenous Immunoglobulin Companies such as Mitsubishi Tanabe Pharma Corporation, Prothya Biosolutions, CSL Behring, AbbVie, Octapharma, Grifols Therapeutics LLC and others.
• Promising Intravenous Immunoglobulin Therapies such as TA-650, Polyethylene Glycol-treated Human Immunoglobulin (VGIH), IVIG-L, IgPro10, Flebogamma 5% DIF, ABBV-383 (Etentamig), Octagam 10% and others.
Stay ahead in the Intravenous Immunoglobulin Therapeutics Market with DelveInsight's Strategic Report @ Intravenous Immunoglobulin Market Outlook- https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Intravenous Immunoglobulin Epidemiology Segmentation in the 7MM
The epidemiology section of Intravenous Immunoglobulin offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Intravenous Immunoglobulin Epidemiology trends @ Intravenous Immunoglobulin Prevalence- https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Intravenous Immunoglobulin Drugs Market
The Intravenous Immunoglobulin Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Intravenous Immunoglobulin signaling in Intravenous Immunoglobulin are likely to uncover new therapeutic targets and further expand treatment options for patients.
Intravenous Immunoglobulin Treatment Market Landscape
The Intravenous Immunoglobulin treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Intravenous Immunoglobulin has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Intravenous Immunoglobulin treatment guidelines, visit @ Intravenous Immunoglobulin Treatment Market Landscape- https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Intravenous Immunoglobulin Market Outlook
The report's outlook on the Intravenous Immunoglobulin market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Intravenous Immunoglobulin therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Intravenous Immunoglobulin drug and late-stage pipeline therapy.
Intravenous Immunoglobulin Drugs Uptake
The drug chapter of the Intravenous Immunoglobulin report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Intravenous Immunoglobulin.
Major Intravenous Immunoglobulin Companies
Mitsubishi Tanabe Pharma Corporation, Prothya Biosolutions, CSL Behring, AbbVie, Octapharma, Grifols Therapeutics LLC and others.
Learn more about the FDA-approved drugs for Intravenous Immunoglobulin @ Drugs for Intravenous Immunoglobulin Treatment- https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Intravenous Immunoglobulin Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Intravenous Immunoglobulin Companies- Mitsubishi Tanabe Pharma Corporation, Prothya Biosolutions, CSL Behring, AbbVie, Octapharma, Grifols Therapeutics LLC and others.
• Intravenous Immunoglobulin Therapies- TA-650, Polyethylene Glycol-treated Human Immunoglobulin (VGIH), IVIG-L, IgPro10, Flebogamma 5% DIF, ABBV-383 (Etentamig), Octagam 10% and others.
• Intravenous Immunoglobulin Market Dynamics: Intravenous Immunoglobulin Market Drivers and Barriers
• Intravenous Immunoglobulin Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Intravenous Immunoglobulin Drugs in development @ Intravenous Immunoglobulin Clinical Trials Assessment- https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Key Insights
2. Intravenous Immunoglobulin Report Introduction
3. Intravenous Immunoglobulin Market Overview at a Glance
4. Executive Summary of Intravenous Immunoglobulin
5. Key Events
6. Intravenous Immunoglobulin Epidemiology and Market Methodology
7. Intravenous Immunoglobulin Disease Background and Overview
8. Intravenous Immunoglobulin Epidemiology and Patient Population
9. Patient Journey
10. Intravenous Immunoglobulin Marketed Therapies
11. Intravenous Immunoglobulin Emerging Therapies
12. Intravenous Immunoglobulin: Market Analysis
13. Intravenous Immunoglobulin KOL Views
14. Intravenous Immunoglobulin SWOT Analysis
15. Intravenous Immunoglobulin Unmet Needs
16. Intravenous Immunoglobulin Market Access
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
List of Top Selling Market Research Reports in 2025
ADHD Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Periodontal disease market- https://www.delveinsight.com/report-store/periodontal-disease-market
Surgical energy instruments Market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Surgical robotic system market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
NK Cell Therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Vital sign monitors devices market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Thrombectomy devices market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Urea cycle disorders market- https://www.delveinsight.com/report-store/urea-cycle-disorders-market
Diabetic wound market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Positive airway pressure device market- https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
LY3454738 drug insight- https://www.delveinsight.com/report-store/moderate-to-severe-atopic-dermatitis-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: +91-9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight |Mitsubishi Tanabe Pharma Corporation, Prothya Biosolutions, CSL Behring, AbbVie, Octapharma, Grifols Therapeutics LLC here
News-ID: 3997063 • Views: …
More Releases from DelveInsight Business Research LLP
Cryopyrin-associated Periodic Syndromes Treatment Market Size in 7MM is expected …
DelveInsight's "Cryopyrin-associated Periodic Syndromes Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Cryopyrin-associated Periodic Syndromes (CAPS), historical and forecasted epidemiology as well as the Cryopyrin-associated Periodic Syndromes (CAPS) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover which therapies are expected to grab the Cryopyrin-associated Periodic Syndromes Market Share @ Cryopyrin-associated Periodic Syndromes Market Outlook-…
WHIM Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "WHIM Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the WHIM, historical and forecasted epidemiology as well as the WHIM market trends in the United States, EU4 and the UK (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Discover which therapies are expected to grab the WHIM Syndrome Market Share @ WHIM Syndrome Market Outlook- https://www.delveinsight.com/sample-request/whim-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the WHIM Syndrome…
Trigeminal Neuralgia Treatment Market Size in 7MM is expected to grow at a decen …
DelveInsight's "Trigeminal Neuralgia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Trigeminal Neuralgia, historical and forecasted epidemiology as well as the Trigeminal Neuralgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Discover which therapies are expected to grab the Trigeminal Neuralgia Market Share @ Trigeminal Neuralgia Market Outlook- https://www.delveinsight.com/sample-request/trigeminal-neuralgia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Trigeminal Neuralgia Market Report
• In…
Inflammatory Myositis Market: Epidemiology, Therapies, Companies, DelveInsight | …
Inflammatory myositis emerging therapies, such as Dazukibart (PF-06823859), and others, are expected to boost the Inflammatory myositis Market in the upcoming years.
DelveInsight has launched a new report on "Inflammatory myositis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Inflammatory myositis, historical and forecasted epidemiology as well as the Inflammatory myositis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom)…
More Releases for Immunoglobulin
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of…
Immunoglobulin Market: Grooming Rapidly in Recent Years
Prophecy Market Insights has recently published the Immunoglobulin informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Immunoglobulin market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry. The report analyses the attractive opportunities…
Immunoglobulin Market Opportunity Analysis, 2018-2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence,…
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from…
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to…
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Global Subcutaneous Immunoglobulin Market: Overview
Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are…
